444 related articles for article (PubMed ID: 21508749)
1. Continuation and satisfaction of reversible contraception.
Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-month continuation of reversible contraception.
O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
[TBL] [Abstract][Full Text] [Related]
3. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
4. Three-year continuation of reversible contraception.
Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
Usinger KM; Gola SB; Weis M; Smaldone A
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
[TBL] [Abstract][Full Text] [Related]
6. Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.
Brunie A; Stankevitz K; Nwala AA; Nqumayo M; Chen M; Danna K; Afolabi K; Rademacher KH
Lancet Glob Health; 2021 Oct; 9(10):e1431-e1441. PubMed ID: 34474001
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of long-acting reversible contraception.
Winner B; Peipert JF; Zhao Q; Buckel C; Madden T; Allsworth JE; Secura GM
N Engl J Med; 2012 May; 366(21):1998-2007. PubMed ID: 22621627
[TBL] [Abstract][Full Text] [Related]
8. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
9. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
10. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
[TBL] [Abstract][Full Text] [Related]
11. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
12. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
13. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
Diedrich JT; Klein DA; Peipert JF
Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
[TBL] [Abstract][Full Text] [Related]
14. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
15. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL; Sanders JN; Turok DK
Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
17. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
Krashin J; Tang JH; Mody S; Lopez LM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
[TBL] [Abstract][Full Text] [Related]
18. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
Allsworth JE; Secura GM; Ajibade OO; Peipert JF
J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
[TBL] [Abstract][Full Text] [Related]
19. Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd).
Black KI; McGeechan K; Watson CJ; Lucke J; Taft A; McNamee K; Haas M; Peipert JF; Mazza D
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):448-453. PubMed ID: 33599984
[TBL] [Abstract][Full Text] [Related]
20. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
